Neoantigen landscape in metastatic nasopharyngeal carcinoma

Lin, M; Zhang, XL; Zou, X; You, R; Yang, Q; Zou, X; Yu, K; Liu, YP; Zou, RH; Hua, YJ; Huang, PY; Wang, J; Zhao, Q; Jiang, XB; Tang, J; Gu, YK; Yu, T; He, GP; Xie, YL; Wang, ZQ; Liu, T; Chen, SY; Zuo, ZX; Chen, MY

Zuo, ZX; Chen, MY (corresponding author), Sun Yat Sen Univ, Dept Nasopharyngeal Carcinoma, Canc Ctr, 651 Dongfeng East Rd, Guangzhou 510060, Peoples R China.; Zuo, ZX; Chen, MY (corresponding author), Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China.; Chen, MY (corresponding author), Guangdong Key Lab Nasopharyngeal Carcinoma Diag &, Guangzhou 510060, Peoples R China.

THERANOSTICS, 2021; 11 (13): 6427

Abstract

Background: Reportedly, nasopharyngeal carcinoma (NPC) patients with MHC I Class aberration are prone to poor survival outcomes, which indicates that ......

Full Text Link